CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.
After hours: March 14 at 7:59:07 PM EDT Loading Chart for MRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback